Wu X, Yang C, Li Z, Lv P, An X, Peng X
Heliyon. 2024; 10(11):e32522.
PMID: 38961909
PMC: 11219504.
DOI: 10.1016/j.heliyon.2024.e32522.
Wu W, Zhu S, Wu Y, Dai L, Zhao J, Jiang Z
Heliyon. 2023; 9(8):e18015.
PMID: 37560663
PMC: 10407678.
DOI: 10.1016/j.heliyon.2023.e18015.
Zhou Z, Cao Q, Diao Y, Wang Y, Long L, Wang S
Front Pharmacol. 2022; 13:1053556.
PMID: 36532760
PMC: 9752855.
DOI: 10.3389/fphar.2022.1053556.
Liu Y, He L, Wang W
Front Oncol. 2022; 12:917667.
PMID: 36110941
PMC: 9468783.
DOI: 10.3389/fonc.2022.917667.
Petkova V, Marinova D, Kyurkchiyan S, Stancheva G, Mekov E, Kachakova-Yordanova D
Medicine (Baltimore). 2022; 101(33):e30027.
PMID: 35984198
PMC: 9388044.
DOI: 10.1097/MD.0000000000030027.
Long noncoding RNA ZFAS1 enhances adriamycin resistance in pediatric acute myeloid leukemia through the miR-195/Myb axis.
Li Q, Wang J
RSC Adv. 2022; 9(48):28126-28134.
PMID: 35530496
PMC: 9071112.
DOI: 10.1039/c9ra04843j.
Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu).
Gao X, Fan X, Zeng W, Liang J, Guo N, Yang X
Bioengineered. 2022; 13(3):7881-7893.
PMID: 35294329
PMC: 9208451.
DOI: 10.1080/21655979.2022.2051266.
Intricate crosstalk between MYB and noncoding RNAs in cancer.
Hu D, Shao W, Liu L, Wang Y, Yuan S, Liu Z
Cancer Cell Int. 2021; 21(1):653.
PMID: 34876130
PMC: 8650324.
DOI: 10.1186/s12935-021-02362-4.
Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.
Rashdan S, Iyengar P, Minna J, Gerber D
Transl Lung Cancer Res. 2021; 10(7):3351-3368.
PMID: 34430372
PMC: 8350108.
DOI: 10.21037/tlcr-21-448.
Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p.
Li J, Fan R, Xiao H
Cancer Cell Int. 2021; 21(1):15.
PMID: 33407505
PMC: 7788748.
DOI: 10.1186/s12935-020-01702-0.
microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.
Tong J, Lu J, Yin Y, Wang Y, Zhang K
Technol Cancer Res Treat. 2020; 19:1533033820977546.
PMID: 33302819
PMC: 7734482.
DOI: 10.1177/1533033820977546.
Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer.
Kong C, Yao Y, Bing Z, Guo B, Huang L, Huang Z
PLoS Comput Biol. 2020; 16(5):e1007793.
PMID: 32428028
PMC: 7295246.
DOI: 10.1371/journal.pcbi.1007793.
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.
Hou J, Wang Y, Zhang H, Hu Y, Xin X, Li X
J Cell Mol Med. 2020; 24(5):2879-2890.
PMID: 31967713
PMC: 7077533.
DOI: 10.1111/jcmm.14859.
Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.
Shih J, Chen H, Lin S, Yeh Y, Shen R, Lang Y
Nucleic Acids Res. 2019; 48(3):1175-1191.
PMID: 31853539
PMC: 7026595.
DOI: 10.1093/nar/gkz1149.
MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2.
Xiao H
Cell Mol Biol Lett. 2019; 24:60.
PMID: 31832068
PMC: 6864997.
DOI: 10.1186/s11658-019-0188-3.
Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1.
Zuo W, Zhang W, Xu F, Zhou J, Bai W
Cancer Cell Int. 2019; 19:240.
PMID: 31528122
PMC: 6739919.
DOI: 10.1186/s12935-019-0934-7.
The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5.
Yu X, Zhang Y, Wu B, Kurie J, Pertsemlidis A
Mol Ther Oncolytics. 2019; 14:288-298.
PMID: 31508486
PMC: 6727248.
DOI: 10.1016/j.omto.2019.07.004.
MiR-302a-5p suppresses cell proliferation and invasion in non-small cell lung carcinoma by targeting ITGA6.
Chen W, Zhuang X, Qi R, Qiao T
Am J Transl Res. 2019; 11(7):4348-4357.
PMID: 31396340
PMC: 6684888.
MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study.
Hu Z, Wang X, Yang Y, Zhao Y, Shen Z, Huang Y
Medicine (Baltimore). 2019; 98(21):e15717.
PMID: 31124951
PMC: 6571392.
DOI: 10.1097/MD.0000000000015717.
MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression.
Xue M, Li G, Sun P, Zhang D, Fang X, Li W
Am J Transl Res. 2019; 11(2):885-894.
PMID: 30899388
PMC: 6413272.